| 英文摘要 |
Cervical cancer remains a significant threat to women's health. In 2022, there were approximately 660,000 new cases and 350,000 deaths globally, the majority of which occurred in low- and middle-income countries with limited medical resources. The key of pathogenesis of cervical cancer lies in persistent infection with high-risk human papillomavirus (HPV); although 90% of infections are cleared by the immune system, chronic infection can gradually lead to precancerous lesions and progress into malignancy. Since the progression typically spans several years, vaccination and regular screening are the cornerstones of cervical cancer prevention. The World Health Organization (WHO) has proposed the ''90-70-90'' strategy: 90% of girls fully vaccinated with the HPV vaccine, 70% of women screened with a high-performance test at least twice, and 90% of diagnosed patients receiving treatment, all aimed at reducing the incidence of cervical cancer. While Taiwan has achieved significant success in its prevention efforts, reaching the elimination standard of ''fewer than 4 cases per 100,000 people annually'' remains a challenge. Future strategies should focus on strengthening health education for high-risk or low-screening-rate populations to bridge the ''prevention gap'' caused by a lack of awareness or psychological barriers. With continuous policy optimization, Taiwan is expected to achieve the goal of eliminating cervical cancer by 2050. |